| |
 |
 |
|
| At MGH, a diabetes research team cured
Type 1 (so-called juvenile) diabetes in 80% of diseased
lab mice. After the team injected the mice for 40 days
with a compound, diseased cells died off and were replaced
by healthy adult stem cells. Previously they identified
a T cell defect in diabetic mice that destroys insulin-producing
beta cells. |
|
|
THE
PACE STUDY
The PACE Study at Brigham and Women's and Massachusetts General
Hospitals is evaluating the effects of epidural analgesia
(pain relief) in childbirth and is supported by the Maternal
and Child Health Bureau, Health Resources and Services Administration,
U.S. Department of Health and Human Services.
HARVARD
CLINICAL RESEARCH INSTITUTE (HCRI)
Harvard Clinical Research Institute (HCRI) is a joint venture
of Harvard Medical School and the CareGroup and Partners HealthCare
organizations. A not-for-profit organization, HCRI works with
industry sponsors to advance patient care through world-class
clinical research. Building on the foundation set forth by
the Cardiovascular Data Analysis Center (CDAC), HCRI draws
on the experience of conducting over 100 medical device, pharmaceutical
and biologic product trials for domestic and international
clients.
HARVARD-PARTNERS CENTER FOR GENETICS
AND GENOMICS
To realize the promise of genetics and genomics in research
and in medical practice, the Harvard Medical School-Partners
Healthcare Center for Genetics and Genomics was established.
Its mission is to promote genetics and genomics in research
and clinical medicine
The Partners AIDS Research Center exists to facilitate multi-disciplinary
AIDS research, promote HIV-related education and training,
and enhance clinical care of HIV-infected persons. The Center
serves both the Massachusetts General Hospital and the Brigham
and Women’s Hospital, and is a natural progression of
the more than twenty year commitment by the clinicians and
scientists at these institutions to HIV and AIDS research
and care.
© Copyright 2008 Partners HealthCare System, Inc.
|
|
